Safety and Efficacy of Apremilast Through 104 Weeks in Patients swith Moderate-to-Severe Psoriasis Who Continued on Apremilast or Switched from Etanercept Treatment in the LIBERATE Study. J of Skin. 2017;1(3.1):s32. doi:10.25251/skin.1.supp.31